The invention relates to a novel composition, particularly a pharmaceuticalcomposition comprising cholest-4-ene-3-one oxime and an oil selected fromsesame oil, olive oil, soybean oil, cottonseed oil, or a commercially availablemixture of medium-chain triglycerides (ESTASAN®, MYGLIOL®), ora mixture of these oils, preferably sesame oil, olive oil or soybean oil, evenmore preferably sesame oil.